Filing Flows › Insulet (PODD) › Free cash flow
Insulet (PODD) free cash flow by quarter
Insulet's free cash flow was $66.4M in Q3 2026 (third quarter 2026), +19% from Q2 2026. Over the last 7 quarters it ranged from $48.2M (Q4 2025) to $178M (Q2 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $66.4M | +19% | -34% |
| Q2 2026 | $55.9M | -38% | -69% |
| Q1 2026 | $89.5M | +86% | +74% |
| Q4 2025 | $48.2M | -52% | — |
| Q3 2025 | $100M | -44% | — |
| Q2 2025 | $178M | +245% | — |
| Q1 2025 | $51.5M | — | — |
Q3 2026 at a glance
Insulet, Q3 2026: revenue $842M (+19% year over year), operating margin 22.5%, net earnings $141M, operating cash flow $124M. The chart follows the revenue to costs, profit and cash.
Questions
What is Insulet's free cash flow?
Insulet's free cash flow was $66.4M in Q3 2026 (third quarter 2026), +19% from Q2 2026.
How has Insulet's free cash flow changed?
Over the last 7 quarters it ranged from $48.2M (Q4 2025) to $178M (Q2 2025).